The status of human papillomavirus vaccination recommendation, funding, and coverage in WHO Europe countries (2018–2019)

Author:

Bonanni Paolo1ORCID,Faivre Pascaline2ORCID,Lopalco Pier Luigi3ORCID,Joura Elmar A.4ORCID,Bergroth Tobias5ORCID,Varga Stefan6ORCID,Gemayel Nathalie7ORCID,Drury Rosybel8ORCID

Affiliation:

1. Department of Health Sciences, University of Florence, Florence, Italy

2. Market Access Vaccines, MSD, Lyon, France

3. Department of Translational Research on New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy

4. Department of Gynecology and Obstetrics, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria

5. Center for Observational and Real-world Evidence, MSD, Stockholm, Sweden

6. Center for Observational and Real-world Evidence, Merck & Co, Inc, Kenilworth, NJ, USA

7. Health Economics & Market Access, Amaris Consulting, Barcelona, Spain

8. Global Vaccines Medical & Scientific Affairs, MSD, Lyon, France

Funder

Merck Sharp & Dohme Corp

Merck & Co., Inc

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Reference27 articles.

1. European Center for Disease Prevention and Control. Factsheet about human papillomavirus; 2020 [cited 2020 Jul 1]. Available from: https://www.ecdc.europa.eu/en/human-papillomavirus/factsheet

2. Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials

3. Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3